Gordon Gary B. 4
4 · Ayala Pharmaceuticals, Inc. · Filed Jan 5, 2022
Insider Transaction Report
Form 4
Gordon Gary B.
Chief Medical Officer
Transactions
- Award
Stock Option
2022-01-03+31,950→ 31,950 totalExercise: $9.11Exp: 2032-01-02→ Common Stock (31,950 underlying)
Footnotes (1)
- [F1]This option vests and becomes exercisable in sixteen substantially equal quarterly installments following the grant date, such that the option shall be fully vested on January 3, 2026.